Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • TimK
    Member
    • Jul 2014
    • 13

    #1

    Qualitative comparison of different RNA-Seq experiments

    Hi,

    I'm trying to do a qualitative comparison of publicly available RNA-Seq datasets from different bacteria. Given that the growth conditions are comparable is it possible, e.g. based on RPKM, to make a qualitative comparison of expression levels of conserved genes?

    Cheers,
    Tim
  • Richard Finney
    Senior Member
    • Feb 2009
    • 701

    #2
    What do you think the problems might be?

    Comment

    • TimK
      Member
      • Jul 2014
      • 13

      #3
      I'm not sure how to compare them. Usually I'd go with something like edgeR or similar for DE analysis. But in this case I'm not sure if that's suitable because it's different bacteria, different experimental setups etc. Therefore, I guess it's more a "gene A of orgA relatively highly expressed, in organismB it's not" ... but what normalization/approach to us? Does that make my problem more clear?

      Tim

      Comment

      • Richard Finney
        Senior Member
        • Feb 2009
        • 701

        #4
        You are, indeed, going to have the problems you mentioned.
        The data is from various sources, prepared differently, using different methods, on different machines analyzing expression for sequences that , though conserved, are different sequences.

        Comparing them with deep certainty about the results is going to be challenging.

        Back in the day, I remember some guys using all the CEL files for Affymetrix expression chips and comparing expression between the various expressions from various sources in NIH's GEO (gene expression omnibus) database. A lot easier with a single chip type and single manufacturer's recommended procedure.

        This EdegeR or DESEQ type approach are good for getting a measure of expression differences, that's not your problem.

        The noise and biases of the various methods used to create the reads is your problem.

        Perhaps limiting data to the best/most used protocols and sequencing machine might a good approach.

        Comment

        • Asaf
          Member
          • Jul 2014
          • 20

          #5
          Maybe you should compare pairs

          You're going to stumble into many normalization issues here. I'm having trouble comparing experiments from the same lab in two different experimental settings, let alone different labs and bacteria.
          I would try another approach using simple statistics. I assume you have enough replicates so you can pair the experiments, taking the two conditions in each bacteria, growth phase, lab etc. and in each pair determine, for each gene, if it was up or down regulated (you'll have to normalize them, using DESeq normalization or other method). Then, if you have about 15 (or even less, depends on the number of genes you're testing) such pairs you can run the sign test on each gene. You should get p-values with sufficient power even after FDR correction.

          Comment

          • mbblack
            Senior Member
            • Aug 2009
            • 245

            #6
            If it were me, I would not even try to merge the two datasets. Analyze each independently just as you would any other cross-species comparison. Pull out your two independent gene lists and look for the overlap between them. Then you can make some comparisons of the commonly detected differential expression in each. First thing I'd want to see is do the two gene lists even rank order correlate at all. You can then do some stats if you wished to compare the independently derived gene lists.
            Michael Black, Ph.D.
            ScitoVation LLC. RTP, N.C.

            Comment

            • TimK
              Member
              • Jul 2014
              • 13

              #7
              Thanks everybody.
              The "simple stats" solution is what I was thinking of, too. I will have a look into sign test and rank order conservation. Thanks for the help so far.

              Comment

              Latest Articles

              Collapse

              • SEQadmin2
                Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
                by SEQadmin2



                CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

                Despite this, “CRISPR helped turn genome editing from a specialized technique into
                ...
                07-31-2026, 11:01 AM
              • SEQadmin2
                Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                by SEQadmin2


                Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                The systematic characterization of the human proteome has
                ...
                07-20-2026, 11:48 AM
              • SEQadmin2
                Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                by SEQadmin2



                Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                ...
                07-09-2026, 11:10 AM

              ad_right_rmr

              Collapse

              News

              Collapse

              Topics Statistics Last Post
              Started by SEQadmin2, 07-31-2026, 02:55 AM
              0 responses
              18 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-24-2026, 12:17 PM
              0 responses
              16 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-23-2026, 11:41 AM
              0 responses
              16 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-20-2026, 11:10 AM
              0 responses
              26 views
              0 reactions
              Last Post SEQadmin2  
              Working...